JS, R., E, H., & GM, L. (2026). An Abbreviated Course of Therapeutic Plasma Exchange Does Not Affect Platelet Count Recovery or Durability in Patients With Immune Thrombotic Thrombocytopenic Purpura Receiving Caplacizumab. Journal of clinical apheresis, 41(3), e70127. https://doi.org/10.1002/jca.70127
Chicago Style (17th ed.) CitationJS, Raval, Hochhaus E, and Lee GM. "An Abbreviated Course of Therapeutic Plasma Exchange Does Not Affect Platelet Count Recovery or Durability in Patients With Immune Thrombotic Thrombocytopenic Purpura Receiving Caplacizumab." Journal of Clinical Apheresis 41, no. 3 (2026): e70127. https://doi.org/10.1002/jca.70127.
MLA (9th ed.) CitationJS, Raval, et al. "An Abbreviated Course of Therapeutic Plasma Exchange Does Not Affect Platelet Count Recovery or Durability in Patients With Immune Thrombotic Thrombocytopenic Purpura Receiving Caplacizumab." Journal of Clinical Apheresis, vol. 41, no. 3, 2026, p. e70127, https://doi.org/10.1002/jca.70127.
